Free Trial
→ Trump’s betrayal exposed (From Porter & Company) (Ad) Buy OTLK Stock  Free OTLK Stock Alerts

Outlook Therapeutics (OTLK) SEC Filings & 10K Form

Outlook Therapeutics logo
$1.25 +0.03 (+2.46%)
Closing price 04:00 PM Eastern
Extended Trading
$1.25 0.00 (0.00%)
As of 06:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Outlook Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
03/30/2025
11:15 PM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form EFFECT
03/28/2025
3:44 PM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 424B3
03/12/2025
8:11 PM		GMS Ventures & Investments (Filed by)
Outlook Therapeutics, Inc. (Subject)
Outlook Therapeutics (Subject)
Form SCHEDULE 13D/A
03/12/2025
7:56 PM		GMS Ventures & Investments (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Sukhtian Ghiath M. (Reporting)
Form 4/A
03/09/2025
11:15 PM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form EFFECT
02/28/2025
3:37 PM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/28/2025
7:17 AM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
3:38 PM		Outlook Therapeutics, Inc. (Subject)
Outlook Therapeutics (Subject)
Form SCHEDULE 13G/A
02/14/2025
7:14 AM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2025
3:16 PM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form DEF 14A
02/10/2025
3:19 PM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form ARS
02/06/2025
3:40 PM		Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Sukhtian Faisal Ghiath (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
3:46 PM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form PRE 14A
01/31/2025
3:39 PM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2025
4:04 PM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
01/23/2025
4:00 PM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 10-K/A
01/22/2025
3:17 PM		GMS Ventures & Investments (Filed by)
Outlook Therapeutics, Inc. (Subject)
Outlook Therapeutics (Subject)
Form SCHEDULE 13D/A
01/16/2025
4:16 PM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2024
3:30 PM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
12/27/2024
7:14 AM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2024
3:11 PM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2024
6:27 AM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2024
11:26 AM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:55 PM		GREAT POINT PARTNERS LLC (Filed by)
Outlook Therapeutics, Inc. (Subject)
Outlook Therapeutics (Subject)
Form SC 13G/A
10/03/2024
8:22 PM		Gangolli Julian S (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM		Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
THURMAN RANDY H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM		HILZINGER KURT J (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM		Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Sukhtian Faisal Ghiath (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM		Haddadin Yezan Munther (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM		Auffarth Gerd (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM		Huang Andong (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM		Haller Julia A (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
3:53 PM		KENYON LAWRENCE A (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
6:48 AM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2024
7:41 AM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2024
6:25 AM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form DEF 14A
05/15/2024
4:19 PM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2024
11:15 PM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form EFFECT
05/01/2024
5:02 AM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
3:18 PM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/17/2024
8:38 PM		Outlook Therapeutics, Inc. (Subject)
Outlook Therapeutics (Subject)
Syntone Ventures LLC (Filed by)
Form SC 13D/A
Brace Yourself for Jeff Bezos’ “Amazon Helios” (Ad)

Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical technology that could change society forever and make early investors rich.

Take these three steps to prepare.
04/17/2024
7:21 PM		Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Syntone Ventures LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
4:21 PM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
04/15/2024
3:53 PM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/12/2024
3:27 PM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 424B5
04/07/2024
11:15 PM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form EFFECT
04/02/2024
3:15 PM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:OTLK) was last updated on 4/2/2025 by MarketBeat.com Staff
From Our Partners
Trump Allies Confirm Exec Order 14024 Triggers Dollar Collapse
Executive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...
Priority Gold | Sponsored
Why Elon Musk Is Investigating Fort Knox
With gold prices recently soaring to record highs over $3,000 an ounce, and central banks rushing to accumulat...
The Oxford Club | Sponsored
Most gold “analysts” aren’t really gold analysts… [watch out]
People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...
Golden Portfolio | Sponsored
“Amazon Coin” set to outperform Bitcoin
Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...
True Market Insiders | Sponsored
Urgent Bitcoin alert for RIGHT NOW
Former billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...
Brownstone Research | Sponsored
Trump’s Secret Weapon
Please don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...
American Alternative | Sponsored
10X Bigger than AI, quantum, EVs, crypto, and robotics combined?
World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...
Stansberry Research | Sponsored
Trump Makes Major Crypto Announcement
Trump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...
Crypto 101 Media | Sponsored